Mehdi Farokhnia

National Institutes of Health

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (25)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Amy Justice

Professor

Yale University School of Medicine

UNITED STATES

View details

Lorenzo Leggio

UNITED STATES

View details

James Hougland

Professor

Syracuse University

UNITED STATES

View details

Sophia Khom

Assistant Professor

Universität Wien

AUSTRIA

View details

Anthony P. Goldstone

UNITED KINGDOM

View details

Laura Orsolini

Assistant Professor

Marche Polytechnic University

ITALY

View details

William Simmons

Associate Professor

Oklahoma State University

UNITED STATES

View details

Christopher Rentsch

Adjunct Assistant Professor

Yale University School of Medicine

UNITED STATES

View details

Joseph Schacht

Associate Professor

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Kusum K. Kharbanda

University of Nebraska Medical Center

UNITED STATES

View details

Vincent Lo Re

UNITED STATES

View details

Claire Pince

University of Colorado Boulder

UNITED STATES

View details

Elisabet Jerlhag

institute of neuroscience and physiology the sahlgrenska academy at the university of gothenburg gothenburg sweden

SWEDEN

View details

Christian Hendershot

Associate Professor

University of North Carolina

UNITED STATES

View details

Anders Fink-Jensen

Professor

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mehdi Farokhnia

Research Interests

Explore related searches

Contact this professor

Articles (25)

Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake

Cocaine craving and use during pharmacotherapy trials for cocaine use disorder: A multi-trajectory analysis

Crosstalk between alcohol use disorder and obesity: two sides of the same coin?

An exploratory analysis of the relationship between ultraprocessed food consumption, alcohol intake, body composition, and cardiometabolic markers in individuals with alcohol use disorder

Bariatric surgery and alcohol and substance use: A case-control survey study

Global overview of short-term alcohol policies: need for global exchange of experience and impact measurement

Alcohol consumption and childhood trauma impact serum immunoglobulin levels in patients with alcohol use disorder

Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder

Spirituality and behavioural addictions: narrative review

Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials

Amylin in Alcohol Addiction: A Potential New Treatment Target or an Adjuvant to Other Treatments?

Lifetime use of alcohol and cannabis among U.S. adolescents across age: Exploring differential patterns by sex and race/ethnicity using the 2019 NSDUH data

A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder

The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission

Initial pharmacological characterization of a major hydroxy metabolite of PF-5190457: inverse agonist activity of PF-6870961 at the ghrelin receptor

GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders

Relationship between self-stigma about alcohol dependence and severity of alcohol drinking and craving

Role of the ghrelin system in alcohol use disorder and alcohol‐associated liver disease: A narrative review

Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies

The glucagon‐like peptide‐1 system is modulated by acute and chronic alcohol exposure: Findings from human laboratory experiments and a post‐mortem brain study

The Mineralocorticoid Receptor: An Emerging Pharmacotherapeutic Target for Alcohol Use Disorder?

Blood Biomarkers of Alcohol Use: A Scoping Review

Effectiveness of spironolactone dispensation in reducing weekly alcohol use: a retrospective high-dimensional propensity score-matched cohort study

Effect of intravenous ghrelin administration, combined with alcohol, on circulating metabolome in heavy drinking individuals with alcohol use disorder

A population-based investigation of the association between alcohol intake and serum total ghrelin concentrations among cigarette-smoking, non-alcohol-dependent male individuals

Collaborators (15)

Amy Justice

Lorenzo Leggio

James Hougland

Sophia Khom

Anthony P. Goldstone

Laura Orsolini

William Simmons

Christopher Rentsch

Joseph Schacht

Kusum K. Kharbanda

Vincent Lo Re

Claire Pince

Elisabet Jerlhag

Christian Hendershot

Anders Fink-Jensen

Make your next move.